×
切換帳號
FAQ
新手指南
FAQ常見問題
學術會議
影音網
登入
×
全站搜尋
搜尋
台灣泌尿科醫學會E-School
登入
FAQ
新手指南
FAQ常見問題
學術會議
影音網
到官網
Home
到官網
Home
知識庫
目錄總覽
文件總覽
最新討論
目錄 / 資料夾
學術活動與演講
年會
2026半年會
摘要
2025年會 (UAA)
摘要
2025半年會
摘要
2024年會
摘要
2024半年會
摘要
2023年會
摘要
2023半年會
摘要
2022年會
摘要
2021年會
摘要
2021半年會
摘要
2020年會
摘要
2020半年會
摘要
2019年會
摘要
2019半年會
摘要
2018年會
摘要
2018半年會
摘要
2017年會
摘要
2017半年會
摘要
2016年會
摘要
2016半年會
摘要
2015年會
摘要
新手指南與FAQ
知識庫
最新上傳
最新上傳
(
熱門
)
最新上傳
(
熱門
)
PD05-05: The safety and efficacy of endoscopic resection of bladder tumor with vela laser– a single center experience
2022-06-07
PD05-04: The prevalence and association of complicated ureteral double-J stent exchange in patients with malignant ureteral obstruction: A single-center, 20 years retrospective study
2022-06-07
PD05-03: Early postoperative outcomes of retroperitoneal partial nephrectomy of anterior and posterior renal tumors: A five-year experience in a single center
2022-06-07
PD05-02: Prognostic factors of disease progression in patients with locally advanced renal cell carcinoma
2022-06-07
PD05-01: Clinical factors that influence the occurrence of renal artery pseudoaneurysms after robotic assisted partial nephrectomy: Single center study of renal function outcomes
2022-06-07
PD04-06: 4-year experience in cmuh for learning curve of MRI/Ultrasound fusion-guided prostate biopsy
2022-06-07
PD04-05: Prostate health index density outperforms prostate health index in clinically significant prostate cancer detection
2022-06-07
PD04-04: Comparison of the clinical outcomes of chemotherapy and novel hormone agents in pre-chemotherapy and post-chemotherapy settings for treatment of metastatic castration-resistant prostate cancer
2022-06-07
PD04-03: The role of urine metabolomics in predicting clinically significant prostate cancer
2022-06-07
PD04-02: Overall survival with Darolutamide versus placebo in combination with androgen-deprivation therapy and Docetaxel for metastatic hormone-sensitive prostate cancer in the phase 3 ARASENS trial
2022-06-07
PD04-01: Active surveillance in Taiwanese men with localized prostate cancer: Outcomes and predicting models
2022-06-07
PD03-06: Combining sperm DNA fragmentation index with computer-assisted semen morphokinematic parameters as a better window into male fertility
2022-06-07
PD03-05: The relationship between antioxidative ingredients of traditional chinese medicine and semen quality in men with infertility
2022-06-07
PD03-04: Loss of MAEL expression sabotages mitochondrial function and impairs human sperm motility
2022-06-07
PD03-03: Outcome of robotic radical cystectomy with intracorporeal J-pouch neobladder in muscle-invasive bladder cancer patient
2022-06-07
PD03-02: Comparing the perioperative outcomes between hand-assisted laparoscopic partial nephrectomy and laparoscopic partial nephrectomy
2022-06-07
PD03-01: The occurrence of inguinal hernia after robotic assisted radical prostatectomy: Clinical characteristics and associated risk factors
2022-06-07
PD02-6: The therapeutic potential of chemoradiotherapy combine with regional hyperthermia therapy for locally advanced bladder cancer- phase III clinical trial preliminary data report
2022-06-07
PD02-5: Predictive factors of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma
2022-06-07
PD02-04: Outcomes of chemotherapy agents as subsequent replacements for discontinued bacillus calmette-guerin bladder instillation in bladder cancer
2022-06-07
PD02-3: Decreased Dehydrogenase/Reductase 2(DHRS2) expression is associated with poor prognosis in urothelial carcinoma patients
2022-06-07
PD02-2: The prognostic significance of ROR2 expression in patients with urothelial carcinoma
2022-06-07
PD02-1: Mir-299-3p inhibits cell proliferation, motility and invasion through VEGFA in upper tract urothelial carcinoma
2022-06-07
PD01-6: Comparison of mini endoscopic combined intrarenal surgery and multitract percutaneous nephrolithotomy specifically for kidney staghorn stones: A single-center experience
2022-06-07
<
64
65
66
67
68
69
70
71
72
73
>
/ 155